MORGAN STANLEY - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 78 filers reported holding DICE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$27,851,330
+1152.1%
599,469
+672.1%
0.00%
Q1 2023$2,224,300
-15.2%
77,637
-7.6%
0.00%
Q4 2022$2,621,581
+240.0%
84,025
+120.8%
0.00%
Q3 2022$771,000
+54.2%
38,057
+18.1%
0.00%
Q2 2022$500,000
+880.4%
32,220
+1105.4%
0.00%
Q1 2022$51,000
-93.8%
2,673
-91.8%
0.00%
Q4 2021$823,00032,5310.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders